UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study

Journal of clinical oncology, 2023-04, Vol.41 (11), p.1999-2006

2023

Volltextzugriff (PDF)

Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2020-01, Vol.38 (3), p.271-280

2020

Volltextzugriff (PDF)

The value of plasma netrin-1 in non-small cell lung cancer patients as diagnostic and prognostic biomarker

Tumor biology, 2016-09, Vol.37 (9), p.11903-11907

2016

Volltextzugriff (PDF)

FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer

Journal of chemotherapy (Florence), 2022-10, Vol.34 (7), p.465-471

2022

Volltextzugriff (PDF)

Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study

Future oncology (London, England), 2022-03, Vol.18 (10), p.1235-1244

2022

Volltextzugriff (PDF)

Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study

Journal of clinical oncology, 2020-07, Vol.38 (21), p.2369-2379

2020

Volltextzugriff (PDF)

PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma

Indian journal of cancer, 2021-10, Vol.58 (4), p.561-566

2021

Volltextzugriff (PDF)

Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?

Expert review of anticancer therapy, 2022-07, Vol.22 (7), p.773-780

2022

Volltextzugriff (PDF)

Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors

World journal of surgical oncology, 2012-02, Vol.10 (1), p.39-39, Article 39

2012

Volltextzugriff (PDF)

Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study

Journal of oncology pharmacy practice, 2021-10, Vol.27 (7), p.1623-1630

2021

Volltextzugriff (PDF)

Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma

Clinical colorectal cancer, 2017-03, Vol.16 (1), p.78-83

2017

Volltextzugriff (PDF)

Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

OncoTargets and therapy, 2018-01, Vol.11, p.419-426

2018

Volltextzugriff (PDF)

Outcome of non-metastatic male breast cancer: 118 patients

Medical oncology (Northwood, London, England), 2012-06, Vol.29 (2), p.554-560

2012

Volltextzugriff (PDF)

CD8+CD28− cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients

Medical oncology (Northwood, London, England), 2010-03, Vol.27 (1), p.29-33

2010

Volltextzugriff (PDF)

Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology

Asian Pacific journal of cancer prevention : APJCP, 2013-01, Vol.14 (12), p.7367-7369

2013

Volltextzugriff (PDF)

Comparison of clinicopathologic and survival characteristics of high grade endometrial cancers; single center experience

Current problems in cancer, 2019-04, Vol.43 (2), p.160-166

2019

Volltextzugriff (PDF)

Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial

The Lancet (British edition), 2020-05, Vol.395 (10236), p.1547-1557

2020

Volltextzugriff (PDF)

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

The Lancet (British edition), 2019-05, Vol.393 (10183), p.1819-1830

2019

Volltextzugriff (PDF)

Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study

BMC cancer, 2004-06, Vol.4 (1), p.29-29, Article 29

2004

Volltextzugriff (PDF)

Is the duration of castration resistance predictive for sequential treatment responses in the metastatic castration-resistant prostate cancer setting?

Journal of oncology pharmacy practice, 2021-08, Vol.27 (6), p.1388-1394

2021

Volltextzugriff (PDF)

Association of lymphadenectomy and survival in epithelial ovarian cancer

Current problems in cancer, 2019-04, Vol.43 (2), p.151-159

2019

Volltextzugriff (PDF)

Retrospective evaluation of premenopausal hormone‐sensitive breast cancer patients treated with adjuvant gonadotropin‐releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study

Asia-Pacific journal of clinical oncology, 2018-04, Vol.14 (2), p.e145-e151

2018

Volltextzugriff (PDF)

Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer

World journal of surgical oncology, 2012-08, Vol.10 (1), p.180-180, Article 180

2012

Volltextzugriff (PDF)

1 – 25 von 137

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(136)
Dissertationen
(1)

Sprache

Englisch
(136)
Türkisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(133)
Science & Technology
(133)
Humans
(107)
Female
(95)
Middle Aged
(92)
Male
(79)
Adult
(77)
Aged
(76)
Retrospective Studies
(47)
Prognosis
(45)
Aged, 80 And Over
(41)
Neoplasm Staging
(35)
Chemotherapy
(32)
Medicine
(27)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(26)
Medicine & Public Health
(26)
Hematology
(24)
Survival Rate
(24)
Treatment Outcome
(23)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study

Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer

The value of plasma netrin-1 in non-small cell lung cancer patients as diagnostic and prognostic biomarker

FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer

Patient‐reported outcomes with cemiplimab monotherapy for first‐line treatment of advanced non–small cell lung cancer with PD‐L1 of ≥50%: The EMPOWER‐Lung 1 study

Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study

Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study

Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study

PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma

Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?

Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors

Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study

Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma

Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

Outcome of non-metastatic male breast cancer: 118 patients

CD8+CD28− cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients

Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology

Comparison of clinicopathologic and survival characteristics of high grade endometrial cancers; single center experience

Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study

Is the duration of castration resistance predictive for sequential treatment responses in the metastatic castration-resistant prostate cancer setting?

Association of lymphadenectomy and survival in epithelial ovarian cancer

Retrospective evaluation of premenopausal hormone‐sensitive breast cancer patients treated with adjuvant gonadotropin‐releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study

Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer

Aktive Filter

Suchergebnisse filtern